E J Rushing1, R A Armonda, Q Ansari, H Mena. 1. Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Texas 75235-9072, USA.
Abstract
BACKGROUND: Mesenchymal chondrosarcomas arising in the central nervous system are extremely rare. Morphologic features have not been found to correlate reliably with prognosis. METHODS: Eight intracranial and five intraspinal mesenchymal chondrosarcomas were reviewed with regard to location, treatment, and long term follow-up data. The histopathologic and immunohistochemical results, including Ki-67 nuclear staining frequency, were critically reviewed, and deoxyribonucleic acid content was analyzed by flow cytometry. RESULTS: Microscopically, all 13 cases were remarkably similar. Immunoreactivity in the small cell component included vimentin in 100% and cytokeratin and glial fibrillary acidic protein in 25% of cases. S-100 immunoreactivity was noted in the cartilaginous component of 100% of cases, and in rare cells in the small cell component along the interface. Flow cytometry of the eight tumors studied revealed a diploid pattern in six, aneuploidy in two, and a wide range of S-phase fractions (0-36.5%). CONCLUSIONS: Review of the literature and the findings of the current series indicates that mesenchymal chondrosarcomas presenting in the brain and spinal cord pursue a progressive course that correlates most reliably with extent of surgical resection. This limited retrospective study also suggests that survival may be shorter for those patients with a high S-phase fraction and a high Ki-67 staining frequency.
BACKGROUND:Mesenchymal chondrosarcomas arising in the central nervous system are extremely rare. Morphologic features have not been found to correlate reliably with prognosis. METHODS: Eight intracranial and five intraspinal mesenchymal chondrosarcomas were reviewed with regard to location, treatment, and long term follow-up data. The histopathologic and immunohistochemical results, including Ki-67 nuclear staining frequency, were critically reviewed, and deoxyribonucleic acid content was analyzed by flow cytometry. RESULTS: Microscopically, all 13 cases were remarkably similar. Immunoreactivity in the small cell component included vimentin in 100% and cytokeratin and glial fibrillary acidic protein in 25% of cases. S-100 immunoreactivity was noted in the cartilaginous component of 100% of cases, and in rare cells in the small cell component along the interface. Flow cytometry of the eight tumors studied revealed a diploid pattern in six, aneuploidy in two, and a wide range of S-phase fractions (0-36.5%). CONCLUSIONS: Review of the literature and the findings of the current series indicates that mesenchymal chondrosarcomas presenting in the brain and spinal cord pursue a progressive course that correlates most reliably with extent of surgical resection. This limited retrospective study also suggests that survival may be shorter for those patients with a high S-phase fraction and a high Ki-67 staining frequency.
Authors: Martin Benesch; André O von Bueren; Tobias Dantonello; Katja von Hoff; Torsten Pietsch; Ivo Leuschner; Alexander Claviez; Uta Bierbach; Gabriele Kropshofer; Rudolf Korinthenberg; Norbert Graf; Meinolf Suttorp; Rolf Dieter Kortmann; Carsten Friedrich; Nicolas von der Weid; Peter Kaatsch; Thomas Klingebiel; Ewa Koscielniak; Stefan Rutkowski Journal: J Neurooncol Date: 2012-12-11 Impact factor: 4.130
Authors: Satoshi Kawaguchi; Israel Weiss; Patrick P Lin; Winston W Huh; Valerae O Lewis Journal: Clin Orthop Relat Res Date: 2014-03 Impact factor: 4.176
Authors: Michael W Bishop; Jessica M Somerville; Armita Bahrami; Sue C Kaste; Rodrigo B Interiano; Jianrong Wu; Shenghua Mao; Frederick A Boop; Regan F Williams; Alberto S Pappo; Sandeep Samant Journal: Sarcoma Date: 2015-06-03
Authors: Carola Andersson; Gustaf Osterlundh; Fredrik Enlund; Lars-Gunnar Kindblom; Magnus Hansson Journal: Oncol Lett Date: 2014-07-18 Impact factor: 2.967